Effectiveness of remimazolam on preventing adverse reactions caused by carboprost tromethamine during cesarean sectio

Not Applicable

Completed

• Conditions: Cesarean section women at risk of postpartum hemorrhage; Pregnancy and Childbirth

• Registration Number: ISRCTN47530284
• Lead Sponsor: Baotou Science and Technology Bureau (????????)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2023-09-30
• Study Start: 2023-11-16
• Last Update Posted: 28 November 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

1. Aged 24-45 years old
2. Indication for cesarean section, planned elective cesarean section
3. American Society of Anesthesiologists (ASA) grade I-II
4. Presence of risk factors for uterine atony, such as scar pregnancy, multiple pregnancies, macrosomia, psychological stress, and making natural labor inappropriate.

Exclusion Criteria

1. Genital tract anomalies
2. Coagulation disorders
3. Allergy to drugs and related solvents intended for use during surgery
4. Pre-existing conditions such as severe gastric ulcers, duodenal ulcers, reflux esophagitis, or other conditions that could lead to symptoms such as nausea, vomiting, chest discomfort, palpitations, abdominal pain, or diarrhea

Study & Design

• Study Type: Interventional
• Study Design: Not specified